Paclitaxel (CAS No. 33069-62-4) in bulk powder form. Paclitaxel is a mitotic inhibitor used in cancer chemotherapy. It is indicated for the treatment of various cancers including ovarian cancer, breast cancer, lung cancer, Kaposi sarcoma, cervical cancers, and pancreatic cancer. In your letter, you indicated Paclitaxel will be used to support generic drug production in finished dosages for various cancer treatments.
Please importantly note that only the relevant portion of the related US CUSTOMS RULING is displayed above. You may refer to the said customs ruling for the entire ruling explanation.